Company: TYRA
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001193125-25-266967
Chunk: 0

Company: Tyra Biosciences, Inc.
Filing Date: 2025-11-05
Form: 10-Q
Item: Item 1
Chunk 0
---
Tyra Biosciences, Inc.Condensed Balance Sheets

(in thousands, except share and per share data)

     September 30,

     December 31,

     2025

     2024

     (unaudited)

     Assets

     Current assets:

     Cash and cash equivalents
      
     $
     61,951

     $
     91,966

     Marketable securities

     212,973

     249,475

     Prepaid expenses and other current assets

     6,292

     6,022

     Total current assets

     281,216

     347,463

     Restricted cash

     1,000

     1,000

     Property and equipment, net

     1,346

     1,651

     Right-of-use assets

     5,699

     6,068

     Other long-term assets

     12,590

     7,376

     Total assets
      
     $
     301,851

     $
     363,558

     Liabilities and Stockholders’ Equity

     Current liabilities:

     Accounts payable
      
     $
     1,991

     $
     590

     Lease liabilities, current

     456

     412

     Accrued expenses and other current liabilities

     13,432

     13,592

     Total current liabilities

     15,879

     14,594

     Lease liabilities, noncurrent

     5,463

     5,810

     Other long-term liabilities

     —

     3

     Total liabilities

     21,342

     20,407

     Commitments and contingencies (Note 9)

     Stockholders’ equity:

     Preferred stock, $0.0001 par value; 50,000,000 shares    authorized at September 30, 2025 and December 31, 2024;     no shares issued and outstanding at September 30, 2025 and    December 31, 2024.

     —

     —

     Common stock, $0.0001 par value; 500,000,000 shares authorized    at September 30, 2025 and December 31, 2024; 53,318,198 and    50,754,262 shares issued